Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol and Memory Reactivation for Pediatric PTSD
NCT04985344Phase 3Recruiting
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Feb 2023
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of propranolol in post-traumatic stress disorder (PTSD), sponsored by Centre hospitalier universitaire de Toulouse. Started Feb 2023; status: recruiting.
02
Drugs
propranolol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04985344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04985344.